Evaxion to announce business update and second quarter 2024 financial results on august 14

Copenhagen, denmark, aug. 12, 2024 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) (“evaxion” or the “company”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, will provide a business update and report its second quarter 2024 financial results on wednesday, august 14, 2024, before opening of the nasdaq-cm.

EVAX Ratings Summary

EVAX Quant Ranking